Connect Biopharma is trading at $2.24 (8% up) today, extending its recent upside amid broad risk-on sentiment and a macro-led rally.
- The stock continues its momentum after closing at $2.07 on August 4, following a 6.1% gain in the previous session.
- The move appears driven by positive sentiment across major U.S. indices and futures rather than new company-specific catalysts.